VisiLoc
SenoRx extends the EnCor breast biopsy product line into the MRI arena by offering grid and pillar/post compatibility in the same EnCor MRI product.
The most significant feature of the MRI product line is the MRI visible obturator, VisiLoc. The VisiLoc obturator provides high visibility through a safe, positive-contrast mechanism that reinforces physician confidence in targeting with each procedure.
July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...
July 07, 2026 
June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...
June 24, 2026 
The majority of MRI scanners require about 1,500 liters of liquid helium to operate, but geopolitical unrest is putting ...
June 17, 2026 
April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...
April 15, 2026 
March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...
March 31, 2026 
March 2, 2026 — A collaborative modeling study found that adding biennial breast magnetic resonance imaging (MRI) to ...
March 20, 2026 
Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...
February 18, 2026 
Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...
February 02, 2026 
Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...
January 29, 2026 
Jan. 27, 2026 — QT Imaging and Olea Medical have announced plans to collaborate. This collaboration enhances QT Imaging ...
January 27, 2026 